Clinical Trials in Los Angeles

Showing 15981-16000 of 16,901 trials

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

NCT00503347

This trial is designed to assess the safety, tolerability, pharmacokinetics and viral kinetics after multiple infusions of bavituximab in patients co-infected with HCV and HIV.

Hepatitis C VirusHiv Infections

Peregrine Pharmaceuticals24 participantsStarted Jul 2007

Los Angeles, California, United States • Newport Beach, California, United States • Atlanta, Georgia, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)

NCT00419705

The purpose of this pivotal study is to demonstrate safety and effectiveness of the NeuroThera® Laser System (referred to hereafter as NTS) in the treatment of Subjects diagnosed with acute ischemic stroke. The initiation of NTS treatment must be feasible for each Subject within 24 hours of stroke onset.

Ischemic Stroke

PhotoThera, Inc660 participantsStarted Dec 2006

Fort Smith, Arkansas, United States • Berkeley, California, United States • Encinitas, California, United States +55 more locations

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)

Find Trials by Condition in Los Angeles

TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment

Improving Health Habits in Impoverished Populations

BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

Intranasal Civamide for Episodic Cluster Headache

Discharge ALERT: Quality Improvement Initiative

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions

A Clinical Trial Assessing Safety of MF101 for Hot Flushes

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension